Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology and infectious disease. The company is headquartered in San Jose, California and currently employs 5 full-time employees. The firm's therapeutic portfolio consists of an ovarian cancer immunotherapy program being developed in collaboration with Moffitt Cancer Center, which uses a novel type of CAR-T, known as chimeric endocrine receptor-T cell (CER-T) technology. The firm's vaccine portfolio includes vaccines being developed in collaboration with Cleveland Clinic to treat and prevent breast cancer and ovarian cancer, as well as additional cancer vaccines to address many intractable cancers, including high incidence malignancies in lung, colon, and prostate. The firm is engaged in the development of vaccines for the treatment or prevention of triple negative breast cancer and other breast cancers which express the a-lactalbumin protein. Its vaccine technologies are focused on immunizing against retired proteins that have been found to be expressed in certain forms of cancer.
How did ANIX's recent EPS compare to expectations?
The most recent EPS for Anixa Biosciences Inc is $, expectations of $-0.08.
How did Anixa Biosciences Inc ANIX's revenue perform in the last quarter?
Anixa Biosciences Inc revenue for the last quarter is $
What is the revenue estimate for Anixa Biosciences Inc?
According to 6 of Wall street analyst, the revenue estimate of Anixa Biosciences Inc range from $0.0 to $0.0
What's the earning quality score for Anixa Biosciences Inc?
Anixa Biosciences Inc has a earning quality score of A-/59.851593. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Anixa Biosciences Inc report earnings?
Anixa Biosciences Inc next earnings report is expected in 2026-08-24
What are Anixa Biosciences Inc's expected earnings?
Anixa Biosciences Inc expected earnings is $0.0, according to wall-street analysts.
Did Anixa Biosciences Inc beat earnings expectations?
Anixa Biosciences Inc recent earnings of $ expectations.